Bacterial duo triggers colorectal cancerUS and Dutch researchers have found that carcinogenic E. coli and B. fragilis versions in the gut of patients who developed precancerous polyps early in life trigger development of colon cancer … more ➔
CRISPR corrects clustered DMD mutationsUsing CRISPR-Cas 9 genome editing, US and German stem cell researchers have corrected clustered mutations in the dystrophin gene in heart mucle cells obtained from induced pluripotent stem cells of patients … more ➔
EPO bows to pressure from industryFollowing critisism from the industry, the European Patent Office has drafted a proposal to allow exemptions to its Early Certainty Initiative. Industry associations had pressed the EPO not to limit … more ➔
Sanofi acquiring AblynxBriefly after Belgian nanobody maker Ablynx rejected a €2.3bn take-over bid of Novo, its board accepted a €3.9bn tender of its R&D partner Sanofi. It’s the second large take-over of Sanofi this … more ➔
EMA recommends seven new drugs for market The European Medicines Agencys Committee for Medicinal Products for Human Use (CHMP) greenlighted seven medicines for approval at its January 2018 meeting, including one orphan medicine, and one biosimilar. more ➔
Bacterium blocks dengue and Zika virus tra... Scientists at the University of Glasgow have found a bacterial strain which blocks dengue and Zika virus transmission from mosquitoes. more ➔
Novartis in US$170m licence deal with Spar...Novartis AG has strengthened its ophtalmology portfolio by acquiring a licence for Spark Therapeutics voretigene neparvovec (Luxturna), an FDA-approved gene therapy that corrects mutations in RPE65, … more ➔
Protein keeps breast cancer metastases at...Spanish researchers have identified a protein that keeps breast cancer stem cell in a dormant state preventing them from forming metastases. A German team found an endothelial receptor protein that prevents … more ➔
Seventure Partners joins US$35m round into...Venture capital firm Seventure Partners has joined a US$35m Series B Round in Digital Nutrition Platform Zipongo. The US$9m invested into the Californian company comes from Seventures €160m Health … more ➔
Sanofi takes over Bioverativ in US$11.8bn...Seven years after the acquisition of Genzyme, French drug major Sanofi has added another orphan drug player to its portfolio. The company agreed with the management of US blood disorder expert Bioverativ … more ➔
